文档介绍：740J Formos Med Assoc | 2010 ? Vol 109 ? No 10Contents lists available at ScienceDirectJournal of the Formosan Medical AssociationJournal homepage: .comJ Formos Med Assoc 2010;109(10):740–773Guideline2010 Guidelines of the Taiwan Society of Cardiologyfor the Management of HypertensionChern-En Chiang,1Tzung-Dau Wang,2Yi-Heng Li,3Tsung-Hsien Lin,4Kuo-Liong Chien,5Hung-I Yeh,6Kou-Gi Shyu,7Wei-Chuen Tsai,3Ting-Hsing Chao,8Juey-Jen Hwang,2Fu-Tien Chiang,9Jyh-Hong Chen3*Hypertension is one of the most important risk factors for atherosclerosis-related mortality and this document, the mittee of the Taiwan Society of Cardiology provides new guide-lines for hypertension management. The key messages are as follows. (1) The life-time risk for hyperten-sion is 90%. (2) Both the increase in the prevalence rate and the relative risk of hypertension for causingcardiovascular events are higher in Asians than in Caucasians. (3) The control rate has been improved sig-nificantly in Taiwan from % to 21% in men, and from 5% to 29% in women in recent years(1995–2002). (4) Systolic and diastolic blood pressure (BP)≥130/80mmHg are thresholds of treatmentfor high-risk patients, such as those with diabetes, chronic kidney disease, stroke, established coronaryheart disease, and coronary heart disease equivalents (carotid artery disease, peripheral arterial disease,and abdominal aortic aneurysm). (5) Ambulatory and home BP monitoring correlate more closely an damage and have a stronger relationship with cardiovascular events than office BP monitoring,but the feasibility of home monitoring makes it a more attractive alternative. (6) Patients with masked hy-pertension have higher cardiovascular risk than those with white-coat hypertension. (7) Lifestyle changesshould be encouraged in all patients, and include the following six items: S-ABCDE (Salt restriction;Alcohol limitation; Body weight reduction; Cessation of smoking; Diet adaptation; Exercise adoption).(8) When pharmacologi